Platelets Antiaggregation Control Enhancement (PACE) Study

Platelets Antiaggregation Control Enhancement Study: an Independent Randomized Blind Prospective Study

Many patients undergo cardiac surgery without proper suspension of antiaggregation drugs. This is blamed to increase dramatically bleeding and use of allogenic blood transfusions. The investigators test the hypothesis that routine use of aggregometry could show antiaggregated patient and lead to normalization of platelet function via administration of Desmopressin thus limiting bleeding and transfusions.

Inclusion Criteria:

• all patients undergoing surgical myocardial revascularization.

Exclusion Criteria:

• none.